Abigail Ann Miller, SAC-IT Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 13111 Lax Chapel Rd, Kiel, WI 53042 Phone: 920-286-4489 |
Andrew James Jacobchick, BA, SAC-IT Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 820 Hwy 67, Kiel, WI 53042 Phone: 920-797-4457 Fax: 920-894-1373 |
Mrs. Brittany Jean Danes, SAC-IT Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 13111 Lax Chapel Rd, Kiel, WI 53042 Phone: 920-286-4488 Fax: 920-894-1373 |
Tristan Albert Ertman, SAC-IT Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 530 State Road 67, Kiel, WI 53042 Phone: 920-894-1374 Fax: 920-894-1373 |
Jeffrey Lee Janikowski, CSAC Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 13111 Lax Chapel Rd, Kiel, WI 53042 Phone: 920-797-4419 Fax: 920-894-4471 |
Angelique Netzband-fischer, SAC Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 13111 Lax Chapel Rd, Kiel, WI 53042 Phone: 920-797-4614 |
News Archive
The Federation of State Medical Boards has released a report recommending best practices for regulating the promotion, communication and practices of treatments received at stem cell clinics in the United States.
Label-free technologies have entered the stage of cellular drug discovery and high-throughput screening (HTS). For the measurement of G protein-coupled receptor (GPCR) activation electrical impedance represents an excellent universal readout technology, since different signaling pathways can be measured in one assay format using recombinant as well as primary cells.
Clostridioides difficile infection (rCDI) occurs in the gut and is caused by the Gram-positive, spore-forming anaerobic bacterium, C. difficile when its spores attach to fecal matter and are transferred from hand to mouth by health care workers.
Researchers from Monash University's Institute of Pharmaceutical Sciences are paving the way for accessible and affordable cancer treatment by using powerful nanoscale tools to overcome the high costs and long lead-times associated with one of the world's newest forms of immunotherapy: CAR-T cell therapy.
› Verified 9 days ago